Frank Loeffler is the new General Manager of Roche Romania

Frank Loeffler was appointed General Manager of Roche Romania, succeeding Claudia Fleischer, who managed the pharmaceutical activity of the local affiliate of Roche Group for the past two years. Claudia Fleischer has been appointed General Manager for Roche Diagnostics GmbH Germany.

With more than 20 years of experience in the pharmaceutical industry, Frank Loeffler started his career with Roche Germany in 2001 in the commercial department. Since 2011, he held various management roles responsible for audit and compliance activities for Roche affiliates across Europe, Middle East, Africa and Asia. From November 2018, Frank has been serving as General Manager for East Africa, overseeing the business of Roche in 10 countries. Frank holds a bachelor degree in Business Administration from the Baden-Wuerttemberg Cooperative State University in Loerrach (Germany).

“I am especially pleased for the opportunity to lead Roche Romania and to bring my contribution to the improvement of outcomes for Romanian patients and the healthcare sector. I want to thank Claudia Fleischer for her dedication in facilitating access to medical innovation and her passion in making personalized healthcare a reality in Romania. Going forward, my wish is to continue to prioritize collaboration for finding innovative ways to ensure broader access to our medical solutions for more patients and the recently adopted National Cancer Plan is a great example of partnering for the wellbeing of the patients. At the same time, I look forward to launching new molecules that address high unmet medical needs in areas such as hematology, neurology, ophthalmology or rare diseases”, declared Frank Loeffler, General Manager, Roche Romania.

In his new position, Frank will continue to focus on Roche mission to deliver more benefits for the Romanian patients and healthcare system, faster and with lower costs to society. He will also foster and build partnerships with a broad collection of stakeholders from the pharmaceutical industry, public and private healthcare sector as well as healthcare authorities to facilitate timely access of the patients to the latest medical innovation.